RepliCel Life Sciences Inc.
RP
株式のランク
#38680
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
株価
$0.01100905
最終同期: 2025-02-28
時価総額
$810.02K
変化（1日）
58.98%
変化（1年）
10,909.05%
国
CA
取引 RepliCel Life Sciences Inc. (RP)
カテゴリー
Healthcare
の時価総額 RepliCel Life Sciences Inc.(RP)
時価総額: $810.02K
October 2026時点で、RepliCel Life Sciences Inc. の時価総額は $810.02K です。これは、当社のデータによると、RepliCel Life Sciences Inc. が世界で38680th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
RepliCel Life Sciences Inc. の時価総額の履歴（2010 から 2026 まで）
